JP2023522628A5 - - Google Patents
Info
- Publication number
- JP2023522628A5 JP2023522628A5 JP2022562440A JP2022562440A JP2023522628A5 JP 2023522628 A5 JP2023522628 A5 JP 2023522628A5 JP 2022562440 A JP2022562440 A JP 2022562440A JP 2022562440 A JP2022562440 A JP 2022562440A JP 2023522628 A5 JP2023522628 A5 JP 2023522628A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazole
- pyridine
- phenyl
- pharmaceutical composition
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0044598 | 2020-04-13 | ||
| KR20200044598 | 2020-04-13 | ||
| KR10-2021-0036863 | 2021-03-22 | ||
| KR1020210036863A KR102386097B1 (ko) | 2020-04-13 | 2021-03-22 | 피라졸 유도체의 폐섬유증 치료제 |
| PCT/KR2021/003537 WO2021210799A1 (ko) | 2020-04-13 | 2021-03-23 | 피라졸 유도체의 폐섬유증 치료제 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522628A JP2023522628A (ja) | 2023-05-31 |
| JP2023522628A5 true JP2023522628A5 (enExample) | 2024-01-05 |
| JP7539485B2 JP7539485B2 (ja) | 2024-08-23 |
Family
ID=78083982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562440A Active JP7539485B2 (ja) | 2020-04-13 | 2021-03-23 | ピラゾール誘導体の肺線維症治療剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12616684B2 (enExample) |
| EP (1) | EP4137134A4 (enExample) |
| JP (1) | JP7539485B2 (enExample) |
| KR (2) | KR102567012B1 (enExample) |
| CN (1) | CN115427039B (enExample) |
| AU (1) | AU2021255160B2 (enExample) |
| BR (1) | BR112022020649A2 (enExample) |
| CA (1) | CA3172596A1 (enExample) |
| CL (1) | CL2022002642A1 (enExample) |
| CO (1) | CO2022014273A2 (enExample) |
| MX (1) | MX2022012726A (enExample) |
| WO (1) | WO2021210799A1 (enExample) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040094464A (ko) * | 2003-05-02 | 2004-11-10 | 학교법인 이화학당 | 피리디닐 피라졸 유도체 |
| KR20120054077A (ko) | 2009-08-21 | 2012-05-29 | 길리아드 바이오로직스, 인크. | 폐 섬유증 장애의 치료를 위한 방법 및 조성물 |
| WO2011028043A2 (ko) | 2009-09-02 | 2011-03-10 | 이화여자대학교 산학협력단 | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 |
| KR101302315B1 (ko) * | 2011-07-19 | 2013-08-30 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 호흡기 질환 예방 및 치료용 조성물 |
| KR101633957B1 (ko) | 2012-08-27 | 2016-06-27 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 신장질환 예방 또는 치료용 조성물 |
| US10548911B2 (en) * | 2014-06-16 | 2020-02-04 | University Of Rochester | Small molecule anti-scarring agents |
| US11096952B2 (en) * | 2016-02-02 | 2021-08-24 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Chemicals and methods to prevent and treat TGF-beta mediated activation of fibroblasts to reduce and treat cancer and fibrosis |
| WO2017192304A1 (en) | 2016-05-02 | 2017-11-09 | Inception 1, Inc. | Arylcarboxamides and uses thereof |
| CA3046158A1 (en) | 2017-01-27 | 2018-08-02 | Genfit | Pharmaceutical compositions for combination therapy |
| KR101821593B1 (ko) | 2017-02-23 | 2018-01-25 | 압타바이오 주식회사 | 안질환 치료제 |
| IL268751B (en) | 2017-03-13 | 2022-08-01 | Genfit | Pharmaceutical preparations for combined treatment |
| CN110536683A (zh) | 2017-04-18 | 2019-12-03 | 基恩菲特公司 | 包含PPAR激动剂如伊拉非诺和乙酰CoA羧化酶ACC抑制剂的组合 |
| KR101856444B1 (ko) | 2017-04-20 | 2018-05-10 | 압타바이오 주식회사 | 3-페닐-4-프로필-1-(피리딘-2-일)-1ｈ-피라졸-5-올 염산염의 신규 결정형 고체 화합물 |
| KR101840702B1 (ko) * | 2017-11-01 | 2018-03-22 | 압타바이오 주식회사 | 간질환 치료제 |
| TWI815938B (zh) | 2018-08-01 | 2023-09-21 | 日商日本化藥股份有限公司 | 具有n-烷基的芳香族胺樹脂、硬化性樹脂組成物及其硬化物 |
| EP3628669A1 (en) | 2018-09-28 | 2020-04-01 | GenKyoTex Suisse SA | Novel compounds as nadph oxidase inhibitors |
| KR102207340B1 (ko) | 2018-10-19 | 2021-01-22 | 한남대학교 산학협력단 | 표면 개질된 다공성 탄소복합소재 및 그 제조방법 |
| CN109912600B (zh) * | 2019-02-22 | 2021-08-03 | 四川大学华西医院 | 一种防治肺纤维化的咪唑并嘧啶类衍生物及其应用 |
| MX2022012472A (es) | 2020-04-08 | 2022-12-15 | Aptabio Therapeutics Inc | Agente para el tratamiento de lesion renal aguda inducida por medio de contraste. |
| WO2021263281A2 (en) * | 2020-06-26 | 2021-12-30 | Ann And Robert H. Lurie Children's Hospital Of Chicago | Methods and compositions for the treatment of covid-19 and associated respiratory distress and multi-organ failure, sepsis, acute respiratory distress syndrome, and cordiovascular diseases |
| UY39671A (es) | 2021-03-15 | 2022-10-31 | Novartis Ag | Derivados de pirazolopiridina y sus usos. |
-
2021
- 2021-03-23 MX MX2022012726A patent/MX2022012726A/es unknown
- 2021-03-23 CN CN202180028319.3A patent/CN115427039B/zh active Active
- 2021-03-23 EP EP21787824.8A patent/EP4137134A4/en active Pending
- 2021-03-23 JP JP2022562440A patent/JP7539485B2/ja active Active
- 2021-03-23 CA CA3172596A patent/CA3172596A1/en active Pending
- 2021-03-23 AU AU2021255160A patent/AU2021255160B2/en active Active
- 2021-03-23 BR BR112022020649A patent/BR112022020649A2/pt unknown
- 2021-03-23 WO PCT/KR2021/003537 patent/WO2021210799A1/ko not_active Ceased
- 2021-03-23 US US17/918,497 patent/US12616684B2/en active Active
- 2021-11-24 KR KR1020210162964A patent/KR102567012B1/ko active Active
-
2022
- 2022-03-16 KR KR1020220032891A patent/KR20220039687A/ko active Pending
- 2022-09-27 CL CL2022002642A patent/CL2022002642A1/es unknown
- 2022-10-05 CO CONC2022/0014273A patent/CO2022014273A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU661307B2 (en) | Antiviral compounds | |
| JP2024516371A5 (enExample) | ||
| JP5286251B2 (ja) | インフルエンザ治療剤 | |
| JP2021063088A5 (enExample) | ||
| JP2018505192A5 (enExample) | ||
| US20100087447A1 (en) | Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination | |
| IL188364A (en) | Pharmaceutical preparation containing S-fluoro-methyl ester of 6 alpha, 9 alpha-difluoro-17 alpha-[(2-furanylcarbonyl) oxy] -11 beta-hydroxy-16 alpha-methyl-3-oxo-androstate-4,1-diane-17-beta-fatty acid As an anti-inflammatory factor | |
| JP2012503668A5 (enExample) | ||
| JP2009539828A5 (enExample) | ||
| JP2014518268A5 (enExample) | ||
| JP2023520323A5 (enExample) | ||
| JP2016529306A5 (enExample) | ||
| SG10201806681YA (en) | Amide compound and use thereof as agent for the treatment and prevention of diseases caused by rna- and/or dna-containing viruses, and concomitant diseases | |
| JP2010270130A5 (enExample) | ||
| JP2019518798A5 (enExample) | ||
| CN115413238A (zh) | 截短侧耳素类化合物的治疗用途 | |
| JP2018507223A5 (enExample) | ||
| WO2020241759A1 (ja) | インフルエンザウイルス感染症またはコロナウイルス感染症の予防および／または治療剤 | |
| CN115867545A8 (zh) | 抗病毒素1,3-二氧代茚化合物 | |
| JP2025142197A5 (enExample) | ||
| JP2022527401A5 (enExample) | ||
| JP2013516475A5 (enExample) | ||
| JP2007518798A5 (enExample) | ||
| PH12022552461A1 (en) | Phd inhibitor compounds, compositions, and use | |
| WO2012173447A3 (ko) | 1,3-다이옥소인덴 유도체, 이의 약학적으로 허용되는 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 항바이러스용 약학적 조성물 |